| 000 | 01613 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515181942.0 | ||
| 264 | 0 | _c20091109 | |
| 008 | 200911s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdp382 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFeinstein, T M | |
| 245 | 0 | 0 |
_aCetuximab-induced aseptic meningitis. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cSep 2009 |
||
| 300 |
_a1609-1610 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Allergic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 | _aCetuximab |
| 650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
| 650 | 0 | 4 |
_aDiphenhydramine _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLaryngeal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningitis, Aseptic _xchemically induced |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPremedication |
| 650 | 0 | 4 |
_aTonsillar Neoplasms _xdrug therapy |
| 700 | 1 | _aGibson, M K | |
| 700 | 1 | _aArgiris, A | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 20 _gno. 9 _gp. 1609-1610 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdp382 _zAvailable from publisher's website |
| 999 |
_c19051338 _d19051338 |
||